Obesity: open trials in Puerto Rico

25 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Trial Treatment · Phase 3 · Eli Lilly and Company
Ponce Medical School Foundation Inc., Ponce · Latin Clinical Trial Center, San Juan · Mgcendo Llc, San Juan
Registry updated 2026-11-05
NCT07919405
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Ponce Med School Found Inc, Ponce
Registry updated 2026-11-05
NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Trial Treatment · Phase 2 · Eli Lilly and Company
Centro de Endocrinologia Alcantara Gonzalez, Bayamón · Mgcendo Llc, San Juan
Registry updated 2026-11-04
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
CMRC Headlands, LLC, San Juan
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
CMRC Headlands, LLC, San Juan
Registry updated 2026-11-04
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Centro de Endocrinologia y Nutricion, Caguas · Dorado Medical Complex, Dorado
Registry updated 2026-11-04
NCT07353931
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Dorado Medical Complex, Dorado · GCM Medical Group, PSC - Hato Rey Site, San Juan
Registry updated 2026-11-04
NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
Advanced Clinical Research, LLC, Bayamón · Isis Clinical Research Center, Guaynabo
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Latin Clinical Trial Center, San Juan
Registry updated 2026-11-04
NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Trial Treatment · Phase 2 · Eli Lilly and Company
Dorado Medical Complex, Dorado · Wellness clinical Research Vega Baja, Vega Baja
Registry updated 2026-11-03
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Medical Research, Ponce · CMRC Headlands, LLC, San Juan · Miralles Clinical Research, San Juan
Registry updated 2026-11-03
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Health and Wellness Institute, Dorado · Puerto Rico Medical Research, Ponce · Mgcendo Llc, San Juan
Registry updated 2026-11-03
NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Trial Treatment · Phase 3 · Amgen
Solace Clinical Research, Bayamón
Registry updated 2026-10-29
NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Trial Treatment · Phase 2 · AbbVie
Advanced Clinical Research - Bayamon /ID# 282250, Bayamón · Clinical Research Investigator Group /ID# 282203, Bayamón · Isis Clinical Res. Ctr P.S.C. /ID# 282252, Guaynabo · Latin Clinical Trial Center - San Juan - Avenida Ponce De Leon /ID# 282248, San Juan
Registry updated 2026-10-27
NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Trial Treatment · Phase 3 · Amgen
Puerto Rico Medical Research Inc., Ponce
Registry updated 2026-10-23
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
FDI Clinical Research, San Juan
Registry updated 2026-10-13
NCT07861100
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Legacy Senior Living, Humacao
Registry updated 2026-10-06
NCT07684144
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Trial Treatment · Phase 3 · Amgen
Latin Clinical Trial Center, San Juan
Registry updated 2026-10-05
NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Trial Treatment · Phase 3 · Amgen
Puerto Rico Medical Research Inc., Ponce · Ponce Medical School Foundation Inc., Ponce · Latin Clinical Trial Center, San Juan
Registry updated 2026-10-05
NCT06439277
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Trial Treatment · Phase 3 · Eli Lilly and Company
University Pediatric Hospital, San Juan
Registry updated 2026-09-24
NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Health and Wellness Institute, Dorado · Wellness clinical Research Vega Baja, Vega Baja
Registry updated 2026-09-22
NCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Torre De Plaza Las Americas, San Juan
Registry updated 2026-08-18
NCT07509307
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Trial Treatment · Phase 3 · Novo Nordisk A/S
Latin Clinical Trial Center Puerto Rico, San Juan
Registry updated 2026-08-17
NCT05962372
Culturally Adapted Dietary Clinical Trial in PR
Trial Treatment · Harvard School of Public Health (HSPH)
Puerto Rico Consortium for Clinical Investigation, San Juan
Registry updated 2026-07-28
NCT03794531
Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico
Research · Harvard School of Public Health (HSPH)
Puerto Rico Consortium for Clinical Investigation, San Juan
Registry updated 2026-05-05

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error